Can Sheehan syndrome (postpartum pituitary gland necrosis) present with withdrawal bleeding due to fluctuating estrogen levels, whereas Asherman syndrome (intrauterine adhesion) does not?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Sheehan Syndrome and Asherman Syndrome Based on Withdrawal Bleeding

Sheehan syndrome can have a withdrawal bleed while Asherman syndrome typically cannot due to the fundamental difference in their pathophysiology - Sheehan's affects hormonal production while Asherman's involves physical scarring of the endometrium.

Pathophysiological Differences

Sheehan Syndrome

  • Definition: Postpartum pituitary necrosis resulting from severe hemorrhage during childbirth 1
  • Mechanism: Ischemic damage to the pituitary gland causing variable degrees of hypopituitarism 2
  • Hormonal Effects:
    • Most commonly affects growth hormone and prolactin secretion
    • Can also affect gonadotropins (FSH/LH), TSH, and ACTH 1
    • Hormonal deficiencies may be partial, allowing for fluctuating estrogen levels

Asherman Syndrome

  • Definition: Intrauterine adhesions/scarring resulting from uterine instrumentation, typically after pregnancy 3
  • Mechanism: Physical scarring of the endometrium causing mechanical obstruction 4
  • Structural Effects:
    • Destruction of the endometrial lining
    • Formation of intrauterine adhesions preventing normal endometrial growth
    • Physical barrier to menstrual flow 4

Withdrawal Bleeding Patterns

Sheehan Syndrome

  • Can have withdrawal bleeding because:
    • The pituitary damage may be partial, allowing for fluctuating estrogen levels
    • When given exogenous progesterone, the endometrium that has been primed by residual estrogen can respond with withdrawal bleeding 5
    • The progestin challenge test may be positive in up to 60% of women with functional hypothalamic amenorrhea, which shares similarities with Sheehan's 5

Asherman Syndrome

  • Cannot typically have withdrawal bleeding because:
    • The endometrium is physically scarred or absent in affected areas
    • Even with hormonal stimulation, there is no functional endometrium to respond 4
    • Physical adhesions prevent the shedding of any endometrial tissue that might grow 3
    • Up to 25% of women may have normal menses if adhesions are partial, but withdrawal bleeding is typically absent in moderate to severe cases 4

Diagnostic Implications

Progestin Challenge Test

  • Sheehan Syndrome: May show withdrawal bleeding if partial pituitary function remains 5
  • Asherman Syndrome: Typically negative regardless of hormonal status due to physical barriers 5

Imaging Findings

  • Sheehan Syndrome: MRI shows empty sella or pituitary atrophy 6
  • Asherman Syndrome: Hysteroscopy is the gold standard, showing intrauterine adhesions 3
    • Hysterosalpingography shows filling defects but is only 16.7% accurate in characterizing intrauterine adhesions 5

Clinical Pearls and Pitfalls

  • Important caveat: The absence of withdrawal bleeding is not diagnostic of Asherman syndrome, as severe cases of Sheehan syndrome with complete pituitary failure will also not have withdrawal bleeding
  • Diagnostic pitfall: Relying solely on withdrawal bleeding patterns without appropriate imaging can lead to misdiagnosis
  • Treatment implications: Hormone replacement therapy is appropriate for Sheehan syndrome 2, while Asherman syndrome requires surgical adhesiolysis 3

Conclusion

The key distinction is that Sheehan syndrome affects hormone production at the pituitary level while potentially preserving the endometrial tissue, allowing for possible withdrawal bleeding with hormone supplementation. In contrast, Asherman syndrome involves physical destruction of the endometrium, preventing withdrawal bleeding regardless of hormonal status.

References

Research

Sheehan syndrome.

Nature reviews. Disease primers, 2016

Research

Sheehan's syndrome.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013

Research

Asherman's syndrome.

Seminars in reproductive medicine, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sheehan Syndrome: An Unusual Presentation Without Inciting Factors.

Women's health reports (New Rochelle, N.Y.), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.